查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
淋巴水腫治療的市場佔有率，規模，趨勢，產業分析:各治療類型，各患部，各終端用戶(醫院，專門診所，門診病人手術中心，其他)，各地區，市場區隔預測(2022年～2030年)
市場調查報告書
商品編碼
1078373

淋巴水腫治療的市場佔有率，規模，趨勢，產業分析:各治療類型，各患部，各終端用戶(醫院，專門診所，門診病人手術中心，其他)，各地區，市場區隔預測(2022年～2030年)

Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region; Segment Forecast, 2022 - 2030
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

全球淋巴水腫治療的市場規模，預計至2030年達到17億3,536萬美元。

本報告提供全球淋巴水腫治療市場調查，市場概要，市場的推動因素與阻礙因素的分析，市場機會，COVID-19的影響，各治療類型、各患部、各終端用戶、各地區的市場分析，競爭情形，主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
    • 調查的目的
    • 市場範圍
    • 前提條件
  • 利害關係者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料來源
    • 第一手資料
    • 第二手資料

第4章 全球淋巴水腫治療市場洞察

  • 產業的概述
  • 市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中)
    • 新加入廠商的威脅(低)
    • 買方議價能力(中)
    • 替代威脅(中)
    • 現有企業間的競爭(高)
  • PESTEL分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球淋巴水腫治療市場:各治療類型

  • 主要調查結果
  • 簡介
    • 各治療類型(2018年～2030年)
  • 壓迫療法
    • 各壓縮療法，各地區(2018年～2030年)
  • 手術
    • 各手術，各地區(2018年～2030年)
  • 藥物療法
    • 各藥物療法，各地區(2018年～2030年)
  • 雷射治療
    • 各雷射治療，各地區(2018年～2030年)
  • 其他
    • 各其他，各地區(2018年～2030年)

第6章 全球淋巴水腫治療市場:各患部

  • 主要調查結果
  • 簡介
    • 各患部(2018年～2030年)
  • 下肢
    • 各下肢，各地區(2018年～2030年)
  • 上肢
    • 各上肢，各地區(2018年～2030年)
  • 性器官
    • 各性器官，各地區(2018年～2030年)

第7章 全球淋巴水腫治療市場:各終端用戶

  • 主要調查結果
  • 簡介
    • 各終端用戶(2018年～2030年)
  • 醫院
    • 各醫院，各地區(2018年～2030年)
  • 專門診所
    • 各專門診所，各地區(2018年～2030年)
  • 門診病人手術中心
    • 各門診病人手術中心，各地區(2018年～2030年)
  • 其他
    • 各其他，各地區(2018年～2030年)

第8章 全球淋巴水腫治療市場:各地區

  • 主要調查結果
  • 簡介
    • 市場評估:各地區(2018年～2030年)
  • 北美
    • 各治療類型(2018年～2030年)
    • 各終端用戶(2018年～2030年)
    • 各患部(2018年～2030年)
    • 美國
    • 加拿大
  • 歐洲
    • 各治療類型(2018年～2030年)
    • 各終端用戶(2018年～2030年)
    • 各患部(2018年～2030年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 奧地利
  • 亞太地區
    • 各治療類型(2018年～2030年)
    • 各終端用戶(2018年～2030年)
    • 各患部(2018年～2030年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲
    • 各治療類型(2018年～2030年)
    • 各終端用戶(2018年～2030年)
    • 各患部(2018年～2030年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 南美
    • 各治療類型(2018年～2030年)
    • 各終端用戶(2018年～2030年)
    • 各患部(2018年～2030年)
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭情形

  • 事業擴張、企業收購的分析
    • 事業擴張
    • 企業收購
  • 夥伴關係/合作/契約/展示會

第10章 企業簡介

  • AIROS Medical Inc.
  • Avet Pharmaceuticals Inc.
  • Bio-compression Systems
  • Cardinal Health
  • Convatec Inc.
  • Essity (BSN medical GmbH)
  • Huntleigh Healthcare Limited
  • JUZO
  • Koya Medical
  • Lohmann & Rauscher
  • Medi GmbH
  • Mego Afek ltd.
  • PAUL HARTMANN
  • SIGVARIS GROUP
  • Smith+Nephew HERANTIS PHARMA Plc
  • Tactile medical
  • ThermoTek
Product Code: PM2314

The global Lymphedema treatment market size is expected to reach USD 1,735.36 million by 2030 according to a new study by Polaris Market Research. The report "Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User (Hospital, Specialty Clinics, Ambulatory Surgical Centers, Others), By Regions; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing number of individuals being affected by Lymphedema is anticipated to drive the growth of the Lymphedema cure industry. Additionally, with the growing prevalence of the disease, innovative and advanced treatments are being developed in order to minimize risk during cure are also surging. Furthermore, the increasing healthcare expenditure coupled with the growing innovation across the healthcare sector is further projected to drive the industry growth. In addition, the launch of new medical devices by pharmaceutical companies is also fueling industry growth across the globe.

Based on the type, the secondary Lymphedema segment is dominating the global industry and is anticipated to lead the industry over the forecasting period. Secondary Lymphedema is generally caused by damage to the Lymph system via cancer treatment through radiation therapy and surgery among others. According to the CDC (Centers for Disease Control & Prevention), the majority of the patients suffer from secondary Lymphedema. Thus, the presence of a large patient pool is anticipated to drive the growth of the segment.

The rising investment by government and private pharmaceutical companies towards R&D for drug discovery is anticipated to present huge industry growth opportunities. Additionally, the growing prevalence of cancer and other chronic diseases is anticipated to drive the growth of the industry. For instance, as per the International Agency for Research on Cancer (IARC), in 2018, there were nearly 17.0 million new cancer cases were recorded, which is likely to grow to 27.5 million new cancer cases by 2040 because of the growth and aging of the population. Thereby, the rising occurrence of cancer is further acts as catalyzing factor for the market growth.

Market participants such as Avet Pharmaceuticals Inc., AIROS Medical Inc., Bio-compression Systems, Cardinal Health, Essity (BSN medical GmbH), Convatec Inc., Huntleigh Healthcare Limited, Koya Medical, JUZO, Medi GmbH, Lohmann & Rauscher, Mego Afek ltd., PAUL HARTMANN, Smith+Nephew HERANTIS PHARMA Plc, SIGVARIS GROUP, Tactile medical, and ThermoTek are some of the key players operating in the global market.

Further, the companies are initiating collaborative initiatives in order to increase their market share. For instance, in August 2021, AIROS Medical, announced an exclusive US distribution deal for fist assist fa-1 compression devices, enabling the company to boost its market presence.

Polaris Market Research has segmented the lymphedema treatment market report on the basis of treatment type, affected area, end-user, and region:

Lymphedema Treatment, Treatment Type Outlook (Revenue - USD Million, 2018 - 2030)

Compression Therapy

Surgery

Drug Therapy

Laser Therapy

Others

Lymphedema Treatment, Affected Area Outlook (Revenue - USD Million, 2018 - 2030)

Lower extremity

Upper extremity

Genitalia

Lymphedema Treatment, End-User Outlook (Revenue - USD Million, 2018 - 2030)

Hospital

Specialty Clinics

Ambulatory Surgical Centers

Others

Lymphedema Treatment, Regional Outlook (Revenue - USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Netherlands

Spain

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Lymphedema Treatment Market Insights

  • 4.1. Lymphedema Treatment - Industry Snapshot
  • 4.2. Lymphedema Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Prevalence of lymphedema and cancer
      • 4.2.1.2. Technological advancements in diagnostic imaging modalities
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Short half-life of radiopharmaceuticals
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Lymphedema Treatment Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Lymphedema Treatment Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • 5.3. Compression Therapy
    • 5.3.1. Global Lymphedema Treatment Market, by Compression Therapy, by Region, 2018 - 2030 (USD Million)
  • 5.4. Surgery
    • 5.4.1. Global Lymphedema Treatment Market, by Surgery, by Region, 2018 - 2030 (USD Million)
  • 5.5. Drug Therapy
    • 5.5.1. Global Lymphedema Treatment Market, by Drug Therapy, by Region, 2018 - 2030 (USD Million)
  • 5.6. Laser Therapy
    • 5.6.1. Global Lymphedema Treatment Market, by Laser Therapy, by Region, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Global Lymphedema Treatment Market, by Others, by Region, 2018 - 2030 (USD Million)

6. Global Lymphedema Treatment Market, by Affected Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • 6.3. Lower extremity
    • 6.3.1. Global Lymphedema Treatment Market, by Lower extremity, by Region, 2018 - 2030 (USD Million)
  • 6.4. Upper extremity
    • 6.4.1. Global Lymphedema Treatment Market, by Upper extremity, by Region, 2018 - 2030 (USD Million)
  • 6.5. Genitalia
    • 6.5.1. Global Lymphedema Treatment Market, by Genitalia, by Region, 2018 - 2030 (USD Million)

7. Global Lymphedema Treatment Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • 7.3. Hospital
    • 7.3.1. Global Lymphedema Treatment Market, by Hospital, by Region, 2018 - 2030 (USD Million)
  • 7.4. Specialty Clinics
    • 7.4.1. Global Lymphedema Treatment Market, by Specialty Clinics, by Region, 2018 - 2030 (USD Million)
  • 7.5. Specialty Clinics
    • 7.5.1. Global Lymphedema Treatment Market, by Specialty Clinics, by Region, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Lymphedema Treatment Market, by Others, by Region, 2018 - 2030 (USD Million)

8. Global Lymphedema Treatment Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Lymphedema Treatment Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • 8.3. Lymphedema Treatment Market - North America
    • 8.3.1. North America: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
    • 8.3.2. North America: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
    • 8.3.3. North America: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.3.4. Lymphedema Treatment Market - U.S.
      • 8.3.4.1. U.S.: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.3.4.2. U.S.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.3.4.3. U.S.: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.3.5. Lymphedema Treatment Market - Canada
      • 8.3.5.1. Canada: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.3.5.2. Canada.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.3.5.3. Canada: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • 8.4. Lymphedema Treatment Market - Europe
    • 8.4.1. Europe: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
    • 8.4.2. Europe.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
    • 8.4.3. Europe: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.4.4. Lymphedema Treatment Market - UK
      • 8.4.4.1. UK: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.4.4.2. UK.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.4.4.3. UK: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.4.5. Lymphedema Treatment Market - France
      • 8.4.5.1. France: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.4.5.2. France.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.4.5.3. France: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.4.6. Lymphedema Treatment Market - Germany
      • 8.4.6.1. Germany: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.4.6.2. Germany.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.4.6.3. Germany: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.4.7. Lymphedema Treatment Market - Italy
      • 8.4.7.1. Italy: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.4.7.2. Italy.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.4.7.3. Italy: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.4.8. Lymphedema Treatment Market - Spain
      • 8.4.8.1. Spain: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.4.8.2. Spain.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.4.8.3. Spain: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.4.9. Lymphedema Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.4.9.2. Netherlands.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.4.9.3. Netherlands: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.4.10. Lymphedema Treatment Market - Austria
      • 8.4.10.1. Austria: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.4.10.2. Austria.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.4.10.3. Austria: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • 8.5. Lymphedema Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
    • 8.5.2. Asia Pacific.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
    • 8.5.3. Asia Pacific: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.5.4. Lymphedema Treatment Market - China
      • 8.5.4.1. China: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.5.4.2. China.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.5.4.3. China: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.5.5. Lymphedema Treatment Market - India
      • 8.5.5.1. India: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.5.5.2. India.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.5.5.3. India: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.5.6. Lymphedema Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.5.6.2. Malaysia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.5.6.3. Malaysia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.5.7. Lymphedema Treatment Market - Japan
      • 8.5.7.1. Japan: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.5.7.2. Japan.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.5.7.3. Japan: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.5.8. Lymphedema Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.5.8.2. Indonesia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.5.8.3. Indonesia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.5.9. Lymphedema Treatment Market - South Korea
      • 8.5.9.1. South Korea: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.5.9.2. South Korea.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.5.9.3. South Korea: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • 8.6. Lymphedema Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
    • 8.6.2. Middle East & Africa.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
    • 8.6.3. Middle East & Africa: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.6.4. Lymphedema Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.6.4.3. Saudi Arabia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.6.5. Lymphedema Treatment Market - UAE
      • 8.6.5.1. UAE: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.6.5.2. UAE.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.6.5.3. UAE: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.6.6. Lymphedema Treatment Market - Israel
      • 8.6.6.1. Israel: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.6.6.2. Israel.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.6.6.3. Israel: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.6.7. Lymphedema Treatment Market - South Africa
      • 8.6.7.1. South Africa: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.6.7.2. South Africa.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.6.7.3. South Africa: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • 8.7. Lymphedema Treatment Market - Latin America
    • 8.7.1. Latin America: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
    • 8.7.2. Latin America.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
    • 8.7.3. Latin America: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.7.4. Lymphedema Treatment Market - Mexico
      • 8.7.4.1. Mexico: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.7.4.2. Mexico.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.7.4.3. Mexico: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.7.5. Lymphedema Treatment Market - Brazil
      • 8.7.5.1. Brazil: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.7.5.2. Brazil.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.7.5.3. Brazil: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
    • 8.7.6. Lymphedema Treatment Market - Argentina
      • 8.7.6.1. Argentina: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
      • 8.7.6.2. Argentina.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
      • 8.7.6.3. Argentina: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AIROS Medical Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Avet Pharmaceuticals Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bio-compression Systems
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cardinal Health
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Convatec Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Essity (BSN medical GmbH)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Huntleigh Healthcare Limited
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. JUZO
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Koya Medical
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Lohmann & Rauscher
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Medi GmbH
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Mego Afek ltd.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. PAUL HARTMANN
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. SIGVARIS GROUP
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Smith+Nephew HERANTIS PHARMA Plc
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Tactile medical
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. ThermoTek
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development

List of Tables

  • Table 1 Global Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 2 Global Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 3 Global Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 4 Lymphedema Treatment Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • Table 5 North America: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 6 North America: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 7 North America: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 8 U.S.: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 9 U.S.: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 10 U.S.: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 11 Canada: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 12 Canada: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 13 Canada: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 14 Europe: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 15 Europe: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 16 Europe: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 17 UK: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 18 UK: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 19 UK: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 20 France: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 21 France: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 22 France: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 23 Germany: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 24 Germany: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 25 Germany: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 26 Italy: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 27 Italy: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 28 Italy: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 29 Spain: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 30 Spain: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 31 Spain: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 32 Netherlands: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 33 Netherlands: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 34 Netherlands: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 35 Austria: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 36 Austria: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 37 Austria: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 41 China: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 42 China: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 43 China: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 44 India: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 45 India: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 46 India: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 47 Malaysia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 48 Malaysia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 49 Malaysia: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 50 Japan: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 51 Japan: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 52 Japan: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 53 Indonesia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 54 Indonesia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 55 Indonesia: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 56 South Korea: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 57 South Korea: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 58 South Korea: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 59 Middle East & Africa: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 60 Middle East & Africa: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 61 Middle East & Africa: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 64 Saudi Arabia: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 65 UAE: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 66 UAE: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 67 UAE: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 68 Israel: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 69 Israel: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 70 Israel: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 71 South Africa: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 72 South Africa: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 73 South Africa: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 74 Latin America: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 75 Latin America: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 76 Latin America: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 77 Mexico: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 78 Mexico: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 79 Mexico: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 80 Brazil: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 81 Brazil: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 82 Brazil: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)
  • Table 83 Argentina: Lymphedema Treatment Market, by Treatment Type, 2018 - 2030 (USD Million)
  • Table 84 Argentina: Lymphedema Treatment Market, by Affected Area, 2018 - 2030 (USD Million)
  • Table 85 Argentina: Lymphedema Treatment Market, by End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Figure 1. Global Lymphedema Treatment Market, 2018 - 2030 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Affected Area
  • Figure 7. Global Lymphedema Treatment Market, by Affected Area, 2021 & 2030 (USD Million)
  • Figure 8. Market by Treatment Type
  • Figure 9. Global Lymphedema Treatment Market, by Treatment Type, 2021 & 2030 (USD Million)
  • Figure 10. Market by End-Use
  • Figure 11. Global Lymphedema Treatment Market, by End-Use, 2021 & 2030 (USD Million)
  • Figure 12. Lymphedema Treatment Market Assessment, By Geography, 2018 - 2030 (USD Million)
  • Figure 13. Strategic Analysis - Lymphedema Treatment Market